These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27491899)

  • 1. Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.
    Fernandes CS; Barbosa I; Castro R; Pina AS; Coroadinha AS; Barbas A; Roque AC
    Biotechnol J; 2016 Dec; 11(12):1513-1524. PubMed ID: 27491899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small synthetic ligands for the enrichment of viral particles pseudotyped with amphotropic murine leukemia virus envelope.
    Fernandes CS; Castro R; Coroadinha AS; Roque AC
    J Chromatogr A; 2016 Mar; 1438():160-70. PubMed ID: 26903473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII.
    Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J
    Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of ceramic fluorapatite-binding peptides from a phage display combinatorial peptide library: optimum affinity tags for fluorapatite chromatography.
    Islam T; Bibi NS; Vennapusa RR; Fernandez-Lahore M
    J Mol Recognit; 2013 Aug; 26(8):341-50. PubMed ID: 23784990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity selection using filamentous phage display.
    Kulseth MA; Fagerlund A; Myrset AH
    Methods Mol Biol; 2014; 1088():67-80. PubMed ID: 24146397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity chromatography for virus-like particle manufacturing: Challenges, solutions, and perspectives.
    Ma J; Tian Z; Shi Q; Dong X; Sun Y
    J Chromatogr A; 2024 Apr; 1721():464851. PubMed ID: 38574547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of phage display methods to identify heptapeptide sequences for use as affinity purification 'tags' with novel chelating ligands in immobilized metal ion affinity chromatography.
    Mooney JT; Fredericks D; Hearn MT
    J Chromatogr A; 2011 Jan; 1218(1):92-9. PubMed ID: 21159343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic biopanning for the selection of peptides with high specificity to Pb2+ from phage displayed peptide library.
    Nian R; Kim DS; Nguyen T; Tan L; Kim CW; Yoo IK; Choe WS
    J Chromatogr A; 2010 Sep; 1217(38):5940-9. PubMed ID: 20709321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23.
    Barkan DT; Cheng XL; Celino H; Tran TT; Bhandari A; Craik CS; Sali A; Smythe ML
    BMC Bioinformatics; 2016 Nov; 17(1):481. PubMed ID: 27881076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity chromatography matures as bioinformatic and combinatorial tools develop.
    Clonis YD
    J Chromatogr A; 2006 Jan; 1101(1-2):1-24. PubMed ID: 16242704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a peptide ligand for affinity purification of factor VIII using phage display.
    Kelley BD; Booth J; Tannatt M; Wub QL; Ladner R; Yuc J; Potter D; Ley A
    J Chromatogr A; 2004 Jun; 1038(1-2):121-30. PubMed ID: 15233528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of mammalian serum albumin affinity purification media by peptide phage display.
    Sato AK; Sexton DJ; Morganelli LA; Cohen EH; Wu QL; Conley GP; Streltsova Z; Lee SW; Devlin M; DeOliveira DB; Enright J; Kent RB; Wescott CR; Ransohoff TC; Ley AC; Ladner RC
    Biotechnol Prog; 2002; 18(2):182-92. PubMed ID: 11934284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of foot-and-mouth disease virus by heparin as ligand for certain strains.
    Du P; Sun S; Dong J; Zhi X; Chang Y; Teng Z; Guo H; Liu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1049-1050():16-23. PubMed ID: 28260627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB).
    Messmer BT; Benham CJ; Thaler DS
    J Mol Biol; 2000 Feb; 296(3):821-32. PubMed ID: 10677284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient one-cycle affinity selection of binding proteins or peptides specific for a small-molecule using a T7 phage display pool.
    Takakusagi Y; Kuramochi K; Takagi M; Kusayanagi T; Manita D; Ozawa H; Iwakiri K; Takakusagi K; Miyano Y; Nakazaki A; Kobayashi S; Sugawara F; Sakaguchi K
    Bioorg Med Chem; 2008 Nov; 16(22):9837-46. PubMed ID: 18930404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells.
    Spear MA; Breakefield XO; Beltzer J; Schuback D; Weissleder R; Pardo FS; Ladner R
    Cancer Gene Ther; 2001 Jul; 8(7):506-11. PubMed ID: 11498772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High avidity binding of engineered papaya mosaic virus virus-like particles to resting spores of Plasmodiophora brassicae.
    Morin H; Tremblay MH; Plante E; Paré C; Majeau N; Hogue R; Leclerc D
    J Biotechnol; 2007 Feb; 128(2):423-34. PubMed ID: 17126944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.
    Zhang Y; Liu Y; Zhang B; Yin S; Li X; Zhao D; Wang W; Bi J; Su Z
    Protein Expr Purif; 2021 Feb; 178():105747. PubMed ID: 32898688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.